secwatch.observer — SEC 8-K summary
======================================

Issuer:     NOVAVAX INC (NVAX)
CIK:        0001000694
Form:       8-K
Filed at:   2023-11-17T23:59:59+00:00
Accession:  0001104659-23-119546
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Novavax appoints John Trizzino as President & COO; Herrmann to retire, Casey to join as CLO
--------------------------------------------------------------------------------

- John Trizzino appointed President and COO (new role), effective November 20, 2023; base salary increased by $50k to $570,000.
- John Herrmann to retire as Chief Legal Officer and Corporate Secretary, effective December 8, 2023.
- Mark Casey to succeed Herrmann as Chief Legal Officer and Corporate Secretary, effective December 11, 2023.
- Herrmann to serve as Senior Advisor under consulting agreement; monthly fee of $44,167 through December 10, 2024, with equity treatment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1000694/000110465923119546/0001104659-23-119546-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1000694/000110465923119546/tm2331053d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-119546

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer